Tandem Diabetes Care (TNDM) Raw Materials (2014 - 2019)

Tandem Diabetes Care (TNDM) has reported Raw Materials for 6 consecutive years, with $9.6 million the latest figure, recorded in Q1 2019.

• For the quarter ending Q1 2019, Raw Materials fell 7.79% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2019 stood at $9.6 million (down 7.79% YoY), and the FY2018 full-year result was $6.6 million, down 35.88% from the prior year.
• Raw Materials improved to $9.6 million in Q1 2019 per TNDM's latest filing, from $6.6 million in the prior quarter.
• Across five years, Raw Materials topped out at $12.1 million in Q2 2016 and bottomed at $6.6 million in Q4 2018.
• Historically, Raw Materials has averaged $9.9 million across 5 years, with a median of $10.0 million in 2016.
• The sharpest annual moves came in 2015 and 2018: Raw Materials surged 49.7% in 2015, then sank 35.88% in 2018.
• Over 5 years, Raw Materials stood at $10.6 million in 2015, then declined by 11.61% to $9.4 million in 2016, then grew by 10.17% to $10.3 million in 2017, then tumbled by 35.88% to $6.6 million in 2018, then jumped by 44.74% to $9.6 million in 2019.
• According to Business Quant data, Raw Materials over the past three periods registered $9.6 million, $6.6 million, and $8.6 million for Q1 2019, Q4 2018, and Q3 2018 respectively.